Hereditary spherocytosis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hereditary spherocytosis}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Hereditary_spherocytosis]]


Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
Line 43: Line 43:
*** Like [[hereditary spherocytosis]], these present with variable degrees of [[anemia]] and [[hemolysis]] and can be [[Diagnosis|diagnosed]] at any [[Ageing|age]].
*** Like [[hereditary spherocytosis]], these present with variable degrees of [[anemia]] and [[hemolysis]] and can be [[Diagnosis|diagnosed]] at any [[Ageing|age]].
*** Unlike the other [[Disorder (medicine)|disorders]], [[Glucose-6-phosphate dehydrogenase deficiency|G6PD deficiency]] typically presents with more discreet episodes of [[hemolysis]] after [[Exposure therapy|exposure]] to [[Oxidant|oxidant drugs]].
*** Unlike the other [[Disorder (medicine)|disorders]], [[Glucose-6-phosphate dehydrogenase deficiency|G6PD deficiency]] typically presents with more discreet episodes of [[hemolysis]] after [[Exposure therapy|exposure]] to [[Oxidant|oxidant drugs]].
*** Unlike the other [[membrane]] [[Disorder (medicine)|disorders]], which each have distinctive morphologies on the blood smear, and the enzyme disorders, which typically have nonspecific findings (eg, mild reticulocytosis), hereditary spherocytosis is characterized by spherocytosis as the predominant morphology.
*** Unlike the other [[membrane]] [[Disorder (medicine)|disorders]], which each have distinctive [[Morphology|morphologies]] on the [[Blood film|blood smear]], and the [[enzyme]] [[Disorder (medicine)|disorders]], which typically have nonspecific findings (eg, [[Reticulocytosis|mild reticulocytosis]]), [[hereditary spherocytosis]] is characterized by [[spherocytosis]] as the predominant [[morphology]].
**Hemolytic disease of the fetus and newborn (HDFN)
**[[Hemolytic disease of the newborn|Hemolytic disease of the fetus and newborn (HDFN)]]
*** Neonates may present with severe HDFN (also called neonatal alloimmune hemolytic anemia), which is caused by maternal antibodies crossing the placenta and recognize foreign fetal RBC antigens, leading to alloimmune hemolysis.
*** [[Infant|Neonates]] may present with severe [[Hemolytic disease of the newborn|HDFN]] (also called [[Hemolytic disease of the newborn|neonatal alloimmune hemolytic anemia]]), which is [[Causality|caused]] by maternal [[antibodies]] crossing the [[placenta]] and recognize [[Foreign bodies|foreign]] [[Fetus|fetal]] [[Red blood cell|RBC]] [[Antigen|antigens]], leading to [[Alloimmunity|alloimmune]] [[hemolysis]].
*** Like hereditary spherocytosis, neonates can present with severe jaundice and anemia requiring aggressive treatment, and HDFN can be associated with abundant spherocytes on the blood smear.
*** Like [[hereditary spherocytosis]], [[Infant|neonates]] can present with severe [[jaundice]] and [[anemia]] requiring aggressive treatment, and [[Hemolytic disease of the newborn|HDFN]] can be [[Association (statistics)|associated]] with abundant [[Spherocytosis|spherocytes]] on the [[Blood film|blood smear]].
*** Unlike hereditary spherocytosis, HDFN is a transient condition that resolves after the maternal antibodies are cleared, and HDFN is characterized by positive Coombs testing, which typically reveals the alloantibodies on fetal RBCs, as well as evidence of an immunologically significant discordance between maternal and neonatal blood type.
*** Unlike [[hereditary spherocytosis]], [[Hemolytic disease of the newborn|HDFN]] is a transient [[Disease|condition]] that resolves after the maternal [[antibodies]] are cleared, and [[Hemolytic disease of the newborn|HDFN]] is characterized by [[Coombs test|positive coombs testing]], which typically reveals the [[Antibody|alloantibodies]] on [[Fetus|fetal]] [[Red blood cell|RBCs]], as well as evidence of an [[Immunology|immunologically]] significant discordance between maternal and [[Infant|neonatal]] [[blood type]].


==References==
==References==

Latest revision as of 20:58, 26 February 2019

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hereditary spherocytosis usually presents with hemolysis, therefore should be differentiated from other diseases including; autoimmune hemolysis, thermal injury, clostridial septicemia, wilson disease, hemoglobinopathies, hereditary stomatocytosis, congenital dyserythropoietic anemia type II, infantile pyknocytosis and hemolytic disease of fetus and newborn (HDFN).

Differential diagnosis

References

  1. Robert D. Christensen, Hassan M. Yaish & Patrick G. Gallagher (2015). "A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates". Pediatrics. 135 (6): 1107–1114. doi:10.1542/peds.2014-3516. PMID 26009624. Unknown parameter |month= ignored (help)
  2. Perrotta, Silverio; Gallagher, Patrick G; Mohandas, Narla (2008). "Hereditary spherocytosis". The Lancet. 372 (9647): 1411–1426. doi:10.1016/S0140-6736(08)61588-3. ISSN 0140-6736.
  3. Bolton-Maggs PH, Langer JC, Iolascon A, Tittensor P, King MJ, General Haematology Task Force of the British Committee for Standards in Haematology (2012). "Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update". Br J Haematol. 156 (1): 37–49. doi:10.1111/j.1365-2141.2011.08921.x. PMID 22055020.
  4. El Nabouch M, Rakotoharinandrasana I, Ndayikeza A, Picard V, Kayemba-Kay's S (2015). "Infantile pyknocytosis, a rare cause of hemolytic anemia in newborns: report of two cases in twin girls and literature overview". Clin Case Rep. 3 (7): 535–8. doi:10.1002/ccr3.288. PMC 4527790. PMID 26273436.

Template:WH Template:WS